Analyst firms · UBS · XP
UBS XP price target and rating history
XP Inc. (XP) · Finance
UBS rates XP Inc. (XP) Buy with a $16 price target, as of its latest action on Jan 24, 2025. It has published 3 rating actions on XP since June 2022, including 2 upgrades and 1 downgrade. Across 4 firms with a XP price target in the last 12 months, the median target is $20.50.
- Current rating
- Buy
- Price target
- $16
- Median target, all firms
- $20.50
- Actions on XP
- 3
UBS price target on XP
Every UBS rating on XP
- Jan 24, 2025
- Jul 11, 2024
- Jun 7, 2022
How other firms rate XP
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Morgan Stanley | Equal-Weight | $19 | Oct 29, 2026 |
| Citigroup | Neutral | $15 | Oct 27, 2026 |
| Itau BBA | Outperform | $27 | Oct 6, 2026 |
| Jefferies | Buy | $22 | Jan 20, 2026 |
Questions about UBS and XP
- What is UBS's price target for XP?
- UBS's latest stated price target for XP Inc. (XP) is $16, from its action on Jan 24, 2025.
- What is UBS's rating on XP?
- UBS rates XP Buy, a bullish rating, as of Jan 24, 2025.
- When did UBS last change its view on XP?
- On Jan 24, 2025, UBS upgrades to Buy from Neutral, price target $19 to $16.
- How does UBS's XP target compare with other analysts?
- Across 4 firms with a XP price target in the last 12 months, the median target is $20.50.
More XP rating histories
All UBS ratingsXP news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.